227 related articles for article (PubMed ID: 2440628)
1. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
[TBL] [Abstract][Full Text] [Related]
2. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
4. Natural killing of fibroblasts infected with low-passage clinical isolates of human cytomegalovirus.
Bandyopadhyay S; Oh SH; Michelson S; Miller DS; Virelizier JL; Starr SE
Clin Exp Immunol; 1988 Jul; 73(1):11-6. PubMed ID: 2844455
[TBL] [Abstract][Full Text] [Related]
5. Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leucocytes.
Starr SE; Garrabrant T
Clin Exp Immunol; 1981 Dec; 46(3):484-92. PubMed ID: 6175462
[TBL] [Abstract][Full Text] [Related]
6. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
7. Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.
Takeda A; Minato N; Kano S
Clin Exp Immunol; 1987 Nov; 70(2):354-63. PubMed ID: 2448073
[TBL] [Abstract][Full Text] [Related]
8. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
9. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
[TBL] [Abstract][Full Text] [Related]
10. Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons.
Wallach D
J Interferon Res; 1982; 2(3):329-38. PubMed ID: 6182251
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
Ostensen ME; Thiele DL; Lipsky PE
J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of human alpha and gamma interferon on mixed lymphocyte culture and on T-cell-mediated cytotoxicity. Inhibition of proliferation but not of IL-2 production by alpha interferons.
Chae F; Oleszak E; Fox FE; Trotta P; Mele CA; Hawrylko E; Platsoucas CD
Int Arch Allergy Appl Immunol; 1988; 86(4):361-9. PubMed ID: 2970436
[TBL] [Abstract][Full Text] [Related]
13. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
14. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 enhances natural killing of varicella-zoster virus-infected targets.
Ito M; Bandyopadhyay S; Matsumoto-Kobayashi M; Clark SC; Miller D; Starr SE
Clin Exp Immunol; 1986 Jul; 65(1):182-9. PubMed ID: 3098472
[TBL] [Abstract][Full Text] [Related]
16. Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.
Bandyopadhyay S; Perussia B; Trinchieri G; Miller DS; Starr SE
J Exp Med; 1986 Jul; 164(1):180-95. PubMed ID: 3014033
[TBL] [Abstract][Full Text] [Related]
17. In vivo activation of murine natural killer cell functions by human recombinant DNA interleukin 2.
Sayers T; Rossiter H; Chung J; Hren A; Armerding D
Immunobiology; 1985 Apr; 169(3):303-18. PubMed ID: 3922876
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
19. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
Rook AH; Masur H; Lane HC; Frederick W; Kasahara T; Macher AM; Djeu JY; Manischewitz JF; Jackson L; Fauci AS; Quinnan GV
J Clin Invest; 1983 Jul; 72(1):398-403. PubMed ID: 6308051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
